Patient clinical data
Patient . | Age at diagnosis (mo)/sex . | ALL lineage . | Disease status at biopsy . | WCC at biopsy (× 109/L) . | Risk category . | Length of CR1 (mo) . | Survival after first relapse (mo) . | Current clinical status . |
---|---|---|---|---|---|---|---|---|
1 | 26/M | B | Relapse 1 | 49.8 | Relapse | 65 | 75* | CR2 |
2 | 65/F | B | Relapse 3 | 1.7 | Relapse | 30 | 46 | DOD |
3 | 154/F | B | Diagnosis | 93.9 | High | 38 | 62* | CR2 |
4 | 105/M | Ph+, B | Diagnosis | 0.43 | High | 10 | 1 | DOD |
5 | 128/F | B | Diagnosis | 2.9 | High | 18* | — | CR1 |
6d | 55/F | B | Diagnosis | 221 | High | 37 | 22* | CR2 |
6r | 55/F | B | Relapse 1 | 8.2 | Relapse | 37 | 22* | CR2 |
7 | 88/M | Biphen | Diagnosis | 12.2 | Standard | 7 | 6 | DOD |
8 | 152/M | T | Relapse 1 | 67.4 | Relapse | 17 | 1 | DOD |
9 | 165/M | T | Diagnosis | 396 | High | 26* | — | CR1 |
10 | 48/M | B | Diagnosis | 51.0 | High | 26* | — | CR1 |
11 | 37/F | B | Diagnosis | 104 | High | 89* | — | CR1 |
12 | 45/M | B | Diagnosis | 28.4 | Standard | 39 | 63* | CR2 |
13 | 69/M | B | Diagnosis | 30.1 | Standard | 21* | — | CR1 |
14 | 51/F | B | Diagnosis | 14.8 | Standard | 22* | — | CR1 |
15 | 177/M | B | Diagnosis | 20.7 | High | 25 | 19 | DOD |
16 | 122/F | T | Diagnosis | 30.5 | High | 72* | — | CR1 |
17 | 107/F | B | Diagnosis | 97.3 | High | 25 | 1* | REL1 |
18 | 30/F | B | Relapse 1 | 7.9 | Relapse | 43 | 21* | CR2 |
19† | 194/M | B | Relapse 1 | 0.39 | Relapse | 3 | 7 | DOD |
Patient . | Age at diagnosis (mo)/sex . | ALL lineage . | Disease status at biopsy . | WCC at biopsy (× 109/L) . | Risk category . | Length of CR1 (mo) . | Survival after first relapse (mo) . | Current clinical status . |
---|---|---|---|---|---|---|---|---|
1 | 26/M | B | Relapse 1 | 49.8 | Relapse | 65 | 75* | CR2 |
2 | 65/F | B | Relapse 3 | 1.7 | Relapse | 30 | 46 | DOD |
3 | 154/F | B | Diagnosis | 93.9 | High | 38 | 62* | CR2 |
4 | 105/M | Ph+, B | Diagnosis | 0.43 | High | 10 | 1 | DOD |
5 | 128/F | B | Diagnosis | 2.9 | High | 18* | — | CR1 |
6d | 55/F | B | Diagnosis | 221 | High | 37 | 22* | CR2 |
6r | 55/F | B | Relapse 1 | 8.2 | Relapse | 37 | 22* | CR2 |
7 | 88/M | Biphen | Diagnosis | 12.2 | Standard | 7 | 6 | DOD |
8 | 152/M | T | Relapse 1 | 67.4 | Relapse | 17 | 1 | DOD |
9 | 165/M | T | Diagnosis | 396 | High | 26* | — | CR1 |
10 | 48/M | B | Diagnosis | 51.0 | High | 26* | — | CR1 |
11 | 37/F | B | Diagnosis | 104 | High | 89* | — | CR1 |
12 | 45/M | B | Diagnosis | 28.4 | Standard | 39 | 63* | CR2 |
13 | 69/M | B | Diagnosis | 30.1 | Standard | 21* | — | CR1 |
14 | 51/F | B | Diagnosis | 14.8 | Standard | 22* | — | CR1 |
15 | 177/M | B | Diagnosis | 20.7 | High | 25 | 19 | DOD |
16 | 122/F | T | Diagnosis | 30.5 | High | 72* | — | CR1 |
17 | 107/F | B | Diagnosis | 97.3 | High | 25 | 1* | REL1 |
18 | 30/F | B | Relapse 1 | 7.9 | Relapse | 43 | 21* | CR2 |
19† | 194/M | B | Relapse 1 | 0.39 | Relapse | 3 | 7 | DOD |